(Q36466785)

14 August 2017

1 reference

title

Pediatric atopic dermatitis: should we treat it differently? (English)

1 reference

14 August 2017

1 reference

Robert Sidbury

1

1 reference

14 August 2017

Solmaz Poorsattar

series ordinal

2

1 reference

14 August 2017

publication date

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

19

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

83-90

1 reference

The prevalence of atopic dermatitis in Oregon schoolchildren

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

The occurrence of atopic dermatitis in north Europe: an international questionnaire study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Consensus conference on pediatric atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Endogenous antimicrobial peptides and skin infections in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Systemic therapy of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Atopic dermatitis: is it an allergic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00061.X

10.1111/J.1529-8019.2006.00061.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference